These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6871885)

  • 1. Phase I study of acivicin in patients with advanced cancer.
    Sridhar KS; Ohnuma T; Chahinian AP; Holland JF
    Cancer Treat Rep; 1983; 67(7-8):701-3. PubMed ID: 6871885
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
    Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
    Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W
    Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of acivicin in malignant mesothelioma.
    Falkson G; Vorobiof DA; Simson IW; Borden EC
    Cancer Treat Rep; 1987 May; 71(5):545-6. PubMed ID: 3567981
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Greco A; Prestridge K; Johnson R
    Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
    Maroun JA; Fields AL; Pater JL; Stewart DJ; Cripps C; Eisenhauer E
    Cancer Treat Rep; 1984 Sep; 68(9):1121-3. PubMed ID: 6478451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of acivicin in advanced metastatic breast cancer.
    Fleishman G; Yap HY; Murphy WK; Bodey G
    Cancer Treat Rep; 1983 Sep; 67(9):843-4. PubMed ID: 6883364
    [No Abstract]   [Full Text] [Related]  

  • 8. Acivicin in 1985.
    Earhart RH; Neil GL
    Adv Enzyme Regul; 1985; 24():179-205. PubMed ID: 3915184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I-II trial of acivicin in adult acute leukemia.
    Powell BL; Craig JB; Capizzi RL; Richards F
    Invest New Drugs; 1988 Apr; 6(1):41-4. PubMed ID: 3165971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study.
    McGuire WP; Blessing JA; DiSaia PJ; Buchsbaum HJ
    Invest New Drugs; 1986; 4(1):49-52. PubMed ID: 3700040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acivicin: a new glutamine antagonist in clinical trials.
    O'Dwyer PJ; Alonso MT; Leyland-Jones B
    J Clin Oncol; 1984 Sep; 2(9):1064-71. PubMed ID: 6470756
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of acivicin in patients with advanced colorectal carcinoma.
    Adolphson CC; Ajani JA; Stroehlein JR; Barlogie B; Bodey GP; Korinek J; Bedikian AY
    Am J Clin Oncol; 1986 Jun; 9(3):189-91. PubMed ID: 3728371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal cancer. A National Cancer Institute of Canada Clinical Trials Group Study.
    Eisenhauer EA; Maroun JA; Fields AL; Walde PL
    Invest New Drugs; 1987 Dec; 5(4):375-8. PubMed ID: 3436743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine.
    Earhart RH; Khandekar JD; Faraggi D; Schinella RA; Davis TE
    Invest New Drugs; 1989 Jul; 7(2-3):255-60. PubMed ID: 2793383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the effectiveness and tolerance of broxaterol in 10 patients with reversible bronchospasm].
    Scoditti S; Paladini A; Stomeo S; Toma P; Aversa C
    Arch Monaldi Mal Torace; 1987; 42(4):383-8. PubMed ID: 2908264
    [No Abstract]   [Full Text] [Related]  

  • 16. Acivicin. An antitumor antibiotic.
    Poster DS; Bruno S; Penta J; Neil GL; McGovren JP
    Cancer Clin Trials; 1981; 4(3):327-30. PubMed ID: 7026076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies.
    Hidalgo M; Rodriguez G; Kuhn JG; Brown T; Weiss G; MacGovren JP; Von Hoff DD; Rowinsky EK
    Clin Cancer Res; 1998 Nov; 4(11):2763-70. PubMed ID: 9829740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I and pharmacological study of acivicin by 24-hour continuous infusion.
    Weiss GR; McGovren JP; Schade D; Kufe DW
    Cancer Res; 1982 Sep; 42(9):3892-5. PubMed ID: 7105049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of tumor and host to hyperalimentation and antiglutamine treatments.
    Chance WT; Cao LQ; Fischer JE
    JPEN J Parenter Enteral Nutr; 1990; 14(2):122-8. PubMed ID: 2112618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I study of weekly maytansine given by iv bolus or 24-hour infusion.
    Chahinian AP; Nogeire C; Ohnuma T; Greenberg ML; Sivak M; Jaffrey IS; Holland JF
    Cancer Treat Rep; 1979; 63(11-12):1953-60. PubMed ID: 526928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.